Profiel
Simon Fricker worked as a Director-Biology at AnorMED, Inc. and as a Vice President-Research at Phio Pharmaceuticals Corp.
He graduated and earned a doctorate degree from the University of Warwick.
Eerdere bekende functies van Simon Fricker
| Bedrijven | Functie | Einde |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Chief Tech/Sci/R&D Officer | 01-12-2022 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Corporate Officer/Principal | - |
Opleiding van Simon Fricker
| University of Warwick | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
